News

A-WARRANTS EXERCISED

THE ENTIRE PRODUCT RANGE FOR HLA TYPING NOW FDA APPROVED FOR SALES IN THE U.S

Q2 2009: Strong foundation for growth

Invitation to presentation of second quarter and first half of 2009 financials

Successful completion of clinical trial for NorDiag's new Bullet BUGS'n BEADS(TM) kit

Strategic deal drives top-line growth

A step forward for NorDiag on the tuberculosis project

Write down of excess value of NOK 23.3 million

Successful completion of NorDiag's swab sample clinical trial tailored to the BD Probetec (TM) ET system

Innovation Norway grants NorDiag new loan of NOK 6 million

Surrender of shares and warrants for primary insider

NorDiag Q1 2009: Business develops according to plan

Cooperation agreement with Kitron

Invitation to presentation of the 1st quarter 2009 results

New distributor in USA

Minutes from Annual General Meeting

NOTICE OF GENERAL MEETING

SUCCESSFUL COMPLETION OF CLINICAL TRIAL FOR NORDIAG's "Bullet" Instrument for automated sample preparation of swab samples

Annual overview

New distributor in France

Pages